"The signing of the manufacturing agreement with NeuExcell showcases our flexibility in supporting biotech companies of all sizes
STATE COLLEGE, Pa. and PHILADELPHIA, Sept. 7, 2021 /PRNewswire/ -- NeuExcell Therapeutics and Spark Therapeutics
STATE COLLEGE, Pa., Aug. 30, 2021 /PRNewswire/ -- NeuExcell Therapeutics (www.neuexcell.com), a gene therapy company
Nature Communications Publication Demonstrates Proof of Principle for Neuroregenerative Approach Pioneered by Founder and Chief Scientific Officer of NeuExcell Therapeutics
It's a race against time when someone suffers a stroke caused by a blockage of a blood vessel supplying the brain.